These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 36640930)
1. Time series analysis revealed prognostic value of continuous nasopharyngeal SARS-CoV-2 nucleic acid quantification for COVID-19: A retrospective study of >3000 COVID-19 patients from 2 centers. Wu Z; Yang C; Shen Y; Zhang Q; Tang X; Wang D; Xu Y; Cao G; Song X; Ma Y; Fan H; Lu H; Li Y; Li X; Shen Y; Zhang C; Zhu M; Teng X; Du Y; Guan M Clin Chim Acta; 2023 Feb; 540():117227. PubMed ID: 36640930 [TBL] [Abstract][Full Text] [Related]
2. IgG Antibodies, SARS-CoV-2 Load, and Prognostic Indicators in Patients with Severe and Mild COVID-19 in Japan. Kashiwagi K; Maeda T; Yoshizawa S; Sato T; Aoki K; Ishii Y; Tateda K J Nippon Med Sch; 2021 Sep; 88(4):380-383. PubMed ID: 33250476 [TBL] [Abstract][Full Text] [Related]
3. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19. Liu Y; Liao W; Wan L; Xiang T; Zhang W Viral Immunol; 2021 Jun; 34(5):330-335. PubMed ID: 32297828 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients. Trunfio M; Venuti F; Alladio F; Longo BM; Burdino E; Cerutti F; Ghisetti V; Bertucci R; Picco C; Bonora S; Di Perri G; Calcagno A Viruses; 2021 Feb; 13(2):. PubMed ID: 33670360 [TBL] [Abstract][Full Text] [Related]
5. Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies. Poon LC; Leung BW; Ma T; Yu FNY; Kong CW; Lo TK; So PL; Leung WC; Shu W; Cheung KW; Moungmaithong S; Wang CC Ultrasound Obstet Gynecol; 2021 Jun; 57(6):974-978. PubMed ID: 33798280 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 infection: Initial viral load (iVL) predicts severity of illness/outcome, and declining trend of iVL in hospitalized patients corresponds with slowing of the pandemic. El Zein S; Chehab O; Kanj A; Akrawe S; Alkassis S; Mishra T; Shatta M; El-Hor N; Salimnia H; Chandrasekar P PLoS One; 2021; 16(9):e0255981. PubMed ID: 34529675 [TBL] [Abstract][Full Text] [Related]
7. Correlation Analysis between the Viral Load and the Progression of COVID-19. Chen W; Xiao Q; Fang Z; Lv X; Yao M; Deng M Comput Math Methods Med; 2021; 2021():9926249. PubMed ID: 34122620 [TBL] [Abstract][Full Text] [Related]
8. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial. Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome. Salto-Alejandre S; Berastegui-Cabrera J; Camacho-Martínez P; Infante-Domínguez C; Carretero-Ledesma M; Crespo-Rivas JC; Márquez E; Lomas JM; Bueno C; Amaya R; Lepe JA; Cisneros JM; Pachón J; Cordero E; Sánchez-Céspedes J; Sci Rep; 2021 Jun; 11(1):12931. PubMed ID: 34155307 [TBL] [Abstract][Full Text] [Related]
10. Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease. Lv Y; Ma Y; Si Y; Zhu X; Zhang L; Feng H; Tian D; Liao Y; Liu T; Lu H; Ling Y Biosci Trends; 2021 May; 15(2):93-99. PubMed ID: 33776018 [TBL] [Abstract][Full Text] [Related]
11. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial. Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289 [TBL] [Abstract][Full Text] [Related]
12. Viral load and its relationship with the inflammatory response and clinical outcomes in hospitalization of patients with COVID-19. Kuri-Ayache M; Rivera-Cavazos A; Pérez-Castillo MF; Santos-Macías JE; González-Cantú A; Luviano-García JA; Jaime-Villalón D; Gutierrez-González D; Romero-Ibarguengoitia ME Front Immunol; 2022; 13():1060840. PubMed ID: 36685564 [TBL] [Abstract][Full Text] [Related]
13. [Related factors of viral nucleic acid change in critically ill patients with SARS-CoV-2 infection after treatment with Nirmatrelvir/Ritonavir: a single center retrospective cohort study]. Yan M; Xie M; Zhu S; Li H; Li S Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Nov; 35(11):1150-1156. PubMed ID: 37987124 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples]. Erman Daloğlu A; Er H; Sepin Özen N; Çekin Y Mikrobiyol Bul; 2022 Apr; 56(2):263-273. PubMed ID: 35477229 [TBL] [Abstract][Full Text] [Related]
15. Association of SARS-CoV-2 cycle threshold (Ct) values with clinical course and serum biomarkers in COVID-19 patients. Saglik I; Ener B; Akalin H; Ozdemir B; Ocakoglu G; Yalcin B; Onal U; Aydin Guçlu O; Acet Ozturk NA; Tuzemen U; Demirdogen E; Gorek Dilektasli A; Agca H; Kazak E; Coskun F; Heper Y; Payaslioglu M; Ediger D; Ursavas A; Yilmaz E; Ozakin C; Uzaslan E; Karadag M J Infect Dev Ctries; 2022 Mar; 16(3):445-452. PubMed ID: 35404849 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of severe acute respiratory syndrome coronavirus-2 viral load and antibodies in patients hospitalized with COVID-19. Bauer RN; Teterina A; Shivram H; McBride J; Rosenberger CM; Cai F; Bao M; Tsai L; Gordon O; Lee IT; Wallin JJ; Porter D; Juneja K; Camus G; Rosas IO; Wildum S Clin Transl Sci; 2023 Jun; 16(6):1049-1062. PubMed ID: 36929625 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19. Chen PZ; Bobrovitz N; Premji ZA; Koopmans M; Fisman DN; Gu FX Elife; 2021 Aug; 10():. PubMed ID: 34414888 [TBL] [Abstract][Full Text] [Related]
18. On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19. Miki S; Sasaki H; Horiuchi H; Miyata N; Yoshimura Y; Miyazaki K; Matsumura T; Takahashi Y; Suzuki T; Matano T; Kawana-Tachikawa A; Tachikawa N PLoS One; 2021; 16(7):e0254640. PubMed ID: 34255796 [TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
20. COVID-19 severity appears to be reduced in spring/summer. Sposato B; Serafini A; Simoncini E; Croci L; Guidoni C; Scalese M; Baratta P; Cresti A; Lacerenza LG; Lena F; Nencioni C; Spargi G; Perrella A; Epidemiol Prev; 2023; 47(1-2):34-46. PubMed ID: 36971236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]